Suzanne Granger

2.8k total citations
23 papers, 888 citations indexed

About

Suzanne Granger is a scholar working on Hematology, Infectious Diseases and Genetics. According to data from OpenAlex, Suzanne Granger has authored 23 papers receiving a total of 888 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 6 papers in Infectious Diseases and 6 papers in Genetics. Recurrent topics in Suzanne Granger's work include Blood groups and transfusion (9 papers), Platelet Disorders and Treatments (6 papers) and HIV Research and Treatment (5 papers). Suzanne Granger is often cited by papers focused on Blood groups and transfusion (9 papers), Platelet Disorders and Treatments (6 papers) and HIV Research and Treatment (5 papers). Suzanne Granger collaborates with scholars based in United States, Canada and Israel. Suzanne Granger's co-authors include Donald Brambilla, Susan F. Assmann, Robert J. Adams, Ronald G. Strauss, Scott T. Miller, Sherrill J. Slichter, Richard M. Kaufman, Sergio Piomelli, Shannon Harkness and Darrell J. Triulzi and has published in prestigious journals such as Blood, Journal of Bone and Joint Surgery and Journal of Clinical Microbiology.

In The Last Decade

Suzanne Granger

23 papers receiving 857 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzanne Granger United States 15 482 327 250 141 140 23 888
Trisha E. Wong United States 14 530 1.1× 457 1.4× 28 0.1× 123 0.9× 77 0.6× 27 851
Marc Zumberg United States 15 284 0.6× 177 0.5× 80 0.3× 29 0.2× 40 0.3× 49 684
Wendy Lau Canada 14 148 0.3× 32 0.1× 99 0.4× 58 0.4× 87 0.6× 38 466
Brian Berman United States 17 723 1.5× 832 2.5× 9 0.0× 168 1.2× 141 1.0× 40 1.3k
Duke O. Kasprisin United States 9 105 0.2× 57 0.2× 46 0.2× 18 0.1× 45 0.3× 18 464
A Concannon Australia 16 446 0.9× 93 0.3× 21 0.1× 94 0.7× 133 0.9× 45 816
David Whiting United States 9 143 0.3× 17 0.1× 92 0.4× 12 0.1× 100 0.7× 13 810
C. A. Reindorf United States 7 878 1.8× 1.1k 3.3× 4 0.0× 249 1.8× 61 0.4× 10 1.2k
María Jesús Rodríguez‐Nieto Spain 11 61 0.1× 25 0.1× 30 0.1× 19 0.1× 142 1.0× 45 522
Adrian Minford United Kingdom 14 553 1.1× 96 0.3× 8 0.0× 53 0.4× 76 0.5× 22 790

Countries citing papers authored by Suzanne Granger

Since Specialization
Citations

This map shows the geographic impact of Suzanne Granger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Granger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Granger more than expected).

Fields of papers citing papers by Suzanne Granger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Granger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Granger. The network helps show where Suzanne Granger may publish in the future.

Co-authorship network of co-authors of Suzanne Granger

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne Granger. A scholar is included among the top collaborators of Suzanne Granger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne Granger. Suzanne Granger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chapman, Kimberly A., et al.. (2023). Neuropsychological endpoints for clinical trials in methylmalonic acidemia and propionic acidemia: A pilot study. Molecular Genetics and Metabolism Reports. 34. 100953–100953. 2 indexed citations
2.
Josephson, Cassandra D., Leslie Raffini, Keith R. McCrae, et al.. (2020). Rituximab for treatment of inhibitors in haemophilia A: A Phase II Study. UNC Libraries. 2 indexed citations
3.
4.
Stowell, Christopher P., Glenn Whitman, Suzanne Granger, et al.. (2016). The impact of red blood cell storage duration on tissue oxygenation in cardiac surgery. Journal of Thoracic and Cardiovascular Surgery. 153(3). 610–619.e2. 9 indexed citations
5.
Burch, Phillip T., Chitra Ravishankar, Jane W. Newburger, et al.. (2016). Assessment of Growth 6 Years after the Norwood Procedure. The Journal of Pediatrics. 180. 270–274.e6. 24 indexed citations
6.
Hess, John R., Felicia Trachtenberg, Susan F. Assmann, et al.. (2016). Clinical and laboratory correlates of platelet alloimmunization and refractoriness in the PLADO trial. Vox Sanguinis. 111(3). 281–291. 38 indexed citations
7.
Assmann, Susan F., Suzanne Granger, Robert D. Christensen, et al.. (2016). Platelet Transfusion Practices Among Very-Low-Birth-Weight Infants. JAMA Pediatrics. 170(7). 687–687. 65 indexed citations
8.
Leissinger, Cindy, Cassandra D. Josephson, Barbara A. Konkle, et al.. (2014). Rituximab for treatment of inhibitors in haemophilia A. Thrombosis and Haemostasis. 112(9). 445–458. 35 indexed citations
9.
Kaufman, Richard M., Susan F. Assmann, Darrell J. Triulzi, et al.. (2014). Transfusion‐related adverse events in the Platelet Dose study. Transfusion. 55(1). 144–153. 63 indexed citations
10.
Triulzi, Darrell J., Susan F. Assmann, Ronald G. Strauss, et al.. (2012). The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopenia. Blood. 119(23). 5553–5562. 94 indexed citations
11.
Caliendo, Angela M., James W. Bremer, Andrea Ferreira‐Gonzalez, et al.. (2011). Multilaboratory Evaluation of Real-Time PCR Tests for Hepatitis B Virus DNA Quantification. Journal of Clinical Microbiology. 49(8). 2854–2858. 47 indexed citations
12.
Leissinger, Cindy, Suzanne Granger, Barbara A. Konkle, et al.. (2011). Phase II Trial of Rituximab in the Treatment of Inhibitors in Congenital Hemophilia A: Results of the RICH Study. Blood. 118(21). 27–27. 4 indexed citations
13.
Kwiatkowski, Janet L., Suzanne Granger, Donald Brambilla, et al.. (2006). Elevated blood flow velocity in the anterior cerebral artery and stroke risk in sickle cell disease: extended analysis from the STOP trial. British Journal of Haematology. 134(3). 333–339. 44 indexed citations
14.
Lee, Margaret T., Sergio Piomelli, Suzanne Granger, et al.. (2006). Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results. Blood. 108(3). 847–852. 206 indexed citations
15.
Jones, Anne M., Suzanne Granger, Donald Brambilla, et al.. (2004). Can peak systolic velocities be used for prediction of stroke in sickle cell anemia?. Pediatric Radiology. 35(1). 66–72. 34 indexed citations
16.
17.
Files, Beatrice, Donald Brambilla, Abdullah Kutlar, et al.. (2002). Longitudinal Changes in Ferritin During Chronic Transfusion: A Report From the Stroke Prevention Trial in Sickle Cell Anemia (STOP). Journal of Pediatric Hematology/Oncology. 24(4). 284–290. 42 indexed citations
18.
Brambilla, Donald, Suzanne Granger, Cheryl Jennings, & James W. Bremer. (2001). Effect of Errors in the Sequence of Optical Densities from the Roche AMPLICOR HIV-1 MONITOR Assay on the Validity of Assay Results. Journal of Clinical Microbiology. 39(3). 1118–1120. 2 indexed citations
19.
Brambilla, Donald, Suzanne Granger, Cheryl Jennings, & James W. Bremer. (2001). Multisite Comparison of Reproducibility and Recovery from the Standard and Ultrasensitive Roche AMPLICOR HIV-1 MONITOR Assays. Journal of Clinical Microbiology. 39(3). 1121–1123. 21 indexed citations
20.
Brinker, Mark R., et al.. (1994). Myelomeningocele at the sacral level. Long-term outcomes in adults.. Journal of Bone and Joint Surgery. 76(9). 1293–1300. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Trisha E. Wong Breakdown of academic impact, for papers by Marc Zumberg Breakdown of academic impact, for papers by Wendy Lau Breakdown of academic impact, for papers by Brian Berman Breakdown of academic impact, for papers by Duke O. Kasprisin Breakdown of academic impact, for papers by A Concannon Breakdown of academic impact, for papers by David Whiting Breakdown of academic impact, for papers by C. A. Reindorf Breakdown of academic impact, for papers by María Jesús Rodríguez‐Nieto Breakdown of academic impact, for papers by Adrian Minford
Rankless by CCL
2026